These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3695478)

  • 1. Pathophysiology of estrogen receptors in mammary tissue by monoclonal antibodies.
    Fabris G; Marchetti E; Marzola A; Bagni A; Querzoli P; Nenci I
    J Steroid Biochem; 1987; 27(1-3):171-6. PubMed ID: 3695478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.
    Garcia M; Lacombe MJ; Duplay H; Cavailles V; Derocq D; Delarue JC; Krebs B; Contesso G; Sancho-Garnier H; Richer G
    J Steroid Biochem; 1987; 27(1-3):439-45. PubMed ID: 3320536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 4. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of histopathologic and immunohistochemical data (using the D5 antibody) and biochemical analysis in the study of estrogen receptors in breast carcinoma].
    Bussolati G; Pietribiasi F; Gugliotta P; Conti G; Di Carlo F
    Pathologica; 1987; 79(1059-1060):45-50. PubMed ID: 3441410
    [No Abstract]   [Full Text] [Related]  

  • 7. Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis.
    Schmitt FC
    Eur J Cancer; 1995 Nov; 31A(12):2049-52. PubMed ID: 8562164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
    Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
    Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic markers of human mammary premalignancy and incipient breast cancer.
    Page DL
    Recent Results Cancer Res; 1988; 106():65-72. PubMed ID: 3285417
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of survivin in different stages of carcinogenesis and progression of breast cancer].
    Zhang SQ; Qiang SY; Yang WB; Jiang JT; Ji ZZ
    Ai Zheng; 2004 Jun; 23(6):697-700. PubMed ID: 15191674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Breast tissue: estrogen receptors. Immunohistochemical and biochemical analysis of normal and hyperplastic tissue and carcinoma in situ. Apropos of 86 cases].
    Jacquemier J; Gandilhon PH; Charpin C; Pourreau-Schneider N; Hassoun J; Martin PM
    Bull Cancer; 1987; 74(2):129-49. PubMed ID: 3038220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone receptors and precancerous lesions of the breast].
    Mignot L; Espie M; de Roquancourt A; Gorins A
    Pathol Biol (Paris); 1983 Nov; 31(9):761-4. PubMed ID: 6318180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign and malignant proliferative epithelial lesions of the breast; a review.
    Azzopardi JG
    Eur J Cancer Clin Oncol; 1983 Dec; 19(12):1717-20. PubMed ID: 6319145
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.
    Shaaban AM; Sloane JP; West CR; Foster CS
    Am J Pathol; 2002 Feb; 160(2):597-604. PubMed ID: 11839580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.